FirmAtlas

Company handbook · COO · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17

COO · CIK 711404 · LATEST FILING: 10-Q JUL '26 · FILED SEP 9, 2026

THE COOPER COMPANIES, INC.

$57.94 +0.54 (+0.94%)

Close, Oct 16, 2026 · 52-week $51–90

↗ coopercos.com

Last fiscal year

THE COOPER COMPANIES, INC. reported revenue of $4.1B for the year ended Oct 31, 2025 (FY25), up 5.1% from FY24. Net income was $375M, operating cash flow $796M and free cash flow $434M. Source: 10-K filed Dec 5, 2025.

Market cap

$11.4B

P/E

19.9

EV/EBITDA

12.9x

P/B

1.4

ROIC

4.3%

Revenue 1Y

5.1%/yr

EPS 1Y

−4.6%/yr

Shares 1Y

−2%

Loading chart…

Daily closes, split-adjusted · ratios at each fiscal year end

Company

CEOAlbert G. White III

HQSan Ramon, CA

AuditorKPMG LLP

Year endsOctober

Revenue by segment · FY25

Coopervision67%

Coopersurgical33%

Compounded growth & averages

10Y

TTM

Share price

2.7%

−10.3%

−11.3%

−19.0%

Upgrade to see 10 years

Share price: yearly compound rate of the traded close; the last column is the past year.

Where the cash went · FY24–FY25

$1.1B deployed

Capex $784M 73.0%

Buybacks $290M 27.0%

Operating cash flow over the period: $1.5B. Total debt changed by −$93M. R&D of $327M is already inside operating costs.

Sources 10-K FY25 10-Q Jul '26 All filings on EDGAR

Latest filings

Sep 9, 2026 Quarterly results 8-K Jun 4, 2026 Quarterly results 8-K May 4, 2026 Executive or director change 8-K Apr 8, 2026 Shareholder vote results 8-K Mar 5, 2026 Quarterly results 8-K

Growth engines

How much of the profit growth came from new investment, and how much from running the business better.

Upgrade to see 10 years

Financials

Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Oct 31, 2025 · change vs previous year

Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier

Per-share figures are split-adjusted (4-for-1 split after FY22).

TTM = the last four quarters, to Jul '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.

Income

FY24 FY25

TTM

Revenue

3,895

4,092+5.1%

4,237

YoY

+5.1%

Gross profit

2,596

2,682+3.3%

2,793

Gross margin

66.6%

65.5%−1.1 pp

—

Operating income

706

683−3.2%

544

Operating margin

18.1%

16.7%−1.4 pp

—

EBITDA

1,081

1,060−1.9%

—

EBITDA margin

27.7%

25.9%−1.8 pp

—

Interest expense

114

100−12.5%

—

Interest coverage

9.46x

10.60x+1.15x

—

Net income

392

375−4.4%

570

YoY

−4.4%

Net margin

10.1%

9.2%−0.9 pp

—

EPS (diluted, $)

1.96

1.87−4.6%

2.93

YoY

−4.6%

Balance sheet

FY24 FY25

TTM

Total assets

12,315

12,395+0.6%

12,673

Cash & short-term investments

108

111+2.7%

—

Accounts receivable

717

829+15.6%

—

Inventory

803

846+5.4%

—

Net PP&E

1,860

2,080+11.8%

—

Other assets

8,827

8,529−3.4%

—

Total liabilities

4,232

4,156−1.8%

4,345

Accounts payable

260

300+15.3%

—

Total debt

2,550

2,458−3.6%

1,916

Other liabilities

1,421

1,398−1.6%

—

Shareholders’ equity

8,083

8,239+1.9%

8,328

Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.

Cash flow statement · as filed

FY24 FY25

TTM

Cash from operations

709

796+12.2%

1,033

Net income

392

375−4.4%

—

Depreciation & amortization

375

377+0.6%

—

Stock-based compensation

70−6.1%

—

Working capital & other

(133)

(27)n/m

—

Cash from investing

(765)

(373)n/m

—

Capex

(421)

(362)n/m

—

Other investing

(343)

(10)n/m

—

Cash from financing

(426)−1186.5%

—

Debt raised

3,524

3,111−11.7%

—

Debt repaid

(3,507)

(3,205)n/m

—

Dividends

0n/m

—

Buybacks

(290)n/m

—

Other financing

(42)−291.3%

—

Net change in cash

(13)

3n/m

—

Free cash flow (OCF − capex)

288

434+50.5%

678

Where the cash went

FY24 FY25

TTM

Operating cash flow

709

796+12.2%

1,033

Reinvested in the business

421

362−14.0%

—

% of operating cash flow

59.4%

45.5%

Capex

421

362−14.0%

355

R&D (memo, already in costs)

155

172+11.0%

—

Free cash flow

288

434+50.5%

678

YoY

+50.5%

Returned to shareholders

290n/m

—

% of free cash flow

0.0%

66.9%

Dividends

0n/m

—

Buybacks

290n/m

—

Change in total debt

—

(93)

—

Cash left over

—

FCF conversion (FCF ÷ net income)

73.4%

115.7%+42.2 pp

—

Owner earnings

—

275

—

Owner earnings margin

—

6.7%

—

Returns & ratios

FY24 FY25

TTM

ROIC (all capital)

4.5%

4.3%−0.2 pp

—

ROIC (operating)

15.2%

13.7%−1.5 pp

—

Net debt / EBITDA

2.26x

2.21x−0.05x

—

Debt / equity

0.32x

0.30x−0.02x

—

Cash conversion cycle (days)

219

215−4 d

—

ROE

4.9%

4.6%−0.3 pp

—

ROA

3.2%

3.0%−0.2 pp

—

ROCE

6.2%

6.1%−0.2 pp

—

NOPAT

475

452−4.9%

—

Invested capital (operating)

3,120

3,454+10.7%

—

Invested capital (all)

10,526

10,586+0.6%

—

Reinvestment rate

—

74.1%

—

Debtor days

74+7 d

—

Inventory days

225

219−6 d

—

Days payable

78+5 d

—

Income

Oct '25

Jan '26

Apr '26

Jul '26

Revenue

1,065

1,024

1,082

1,066

vs year-ago quarter

Gross profit

651

695

735

712

Gross margin

61.1%

67.9%

68.0%

66.8%

Operating income

140

213

(31)

222

Net income

131

(78)

433

vs year-ago quarter

Net margin

7.9%

12.8%

−7.2%

40.6%

EPS (diluted, $)

0.43

0.66

−0.40

2.24

vs year-ago quarter

Balance sheet

Oct '25

Jan '26

Apr '26

Jul '26

Total assets

12,395

12,424

12,482

12,673

Cash & equivalents

111

125

139

155

Total debt

2,458

1,879

1,861

1,916

Shareholders’ equity

8,239

8,364

8,239

8,328

Cash flow

Oct '25

Jan '26

Apr '26

Jul '26

Operating cash flow

248

261

183

342

Capex

102

Free cash flow

150

159

273

vs year-ago quarter